What is GermBlast?
GermBlast operates as a premier provider of comprehensive disinfection and infection prevention solutions. By integrating advanced biological cleanup protocols with mobile equipment decontamination and air quality testing, the firm serves a diverse portfolio of high-stakes environments, including healthcare facilities, educational institutions, and government infrastructure. Beyond its core service offerings, GermBlast distinguishes itself through technological innovation, specifically via its GermStats software, which provides real-time environmental health monitoring. This dual-pronged approach of physical remediation and digital oversight positions the company as a critical partner in maintaining public health standards across the Southwest and expanding regional markets.
How much funding has GermBlast raised?
GermBlast has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in GermBlast
PPP
Public-Private Partnership
What's next for GermBlast?
With the recent influx of capital, GermBlast is poised to transition into a phase of aggressive scaling and technological refinement. The strategic roadmap likely involves the expansion of its GB Flooring product line and the further integration of its GermStats analytics platform into broader commercial applications. As the company navigates this late-stage growth cycle, management will likely prioritize operational efficiency and the acquisition of new market share in the institutional disinfection space. By leveraging its established reputation for rigorous biological cleanup, GermBlast is set to solidify its status as an essential utility in the modern infrastructure of public and private health safety.
See full GermBlast company page
